Avidity Partners Management LP Rocket Pharmaceuticals, Inc. Transaction History

Avidity Partners Management LP

$1.63 Billion
Q3 2024

A detailed history of Avidity Partners Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 749,000 shares of RCKT stock, worth $9.77 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

749,000

Previous 1,100,000 31.91%

Holding current value

$9.77 Million

Previous $23.7 Million 41.59%

% of portfolio

0.85%

Previous 1.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $6.18 Million - $9.08 Million	-351,000 Reduced 31.91%	749,000 $13.8 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $1.55 Million - $2 Million	75,000 Added 7.32%	1,100,000 $23.7 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $18.2 Million - $21.3 Million	-694,103 Reduced 40.38%	1,025,000 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $2.21 Million - $4.21 Million	131,674 Added 8.29%	1,719,103 $51.5 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $3.94 Million - $6.29 Million	261,429 Added 19.72%	1,587,429 $32.5 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $1.35 Million - $1.93 Million	81,600 Added 6.56%	1,326,000 $26.3 Million
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $4.46 Million - $6.39 Million	-282,687 Reduced 18.51%	1,244,400 $21.3 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $23.7 Million - $34.8 Million	1,527,087 New	1,527,087 $29.9 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $2.17 Million - $3.3 Million	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $1.17 Million - $2.98 Million	50,000 New	50,000 $2.74 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $291,300 - $753,300	-30,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$11.07 - $24.23 $332,100 - $726,900	30,000 New	30,000 $683,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Rocket Pharmaceuticals, Inc. Transaction History